Thumbnail for Kallyope
New York City, US · 3 known investors
Kallyope discovers and develops novel therapeutics targeting previously unexplored neural networks, with lead programs in acute migraine treatment and novel metabolism disorders. The company leverages its proprietary Klarity platform to identify differentiated drug candidates for patients with challenging diseases.
BiotechDeep TechMedical Devices